Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Ulcerative Colitis
NCT05567068Phase 2Completed
- Sponsor
- Tanta University
- Start
- Feb 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of atorvastatin in ulcerative colitis (UC) (2 arms), sponsored by Tanta University. Primary endpoint: Health related quality of life at 6 months. Started Feb 2023; status: completed.
02
Drugs
atorvastatin
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05567068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05567068.